The Asklepios Group posted significant organic growth again in the third quarter of 2014. In the first nine months, Asklepios treated a total of 1,635,943 patients, a 2.8% increase on the same period of the previous year. Revenue increased by 4.2% to EUR 2,263.3 million (9M 2013: EUR 2,173.0 million).